Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q3K110

Entry ID Method Resolution Chain Position Source
AF-Q3K110-F1 Predicted AlphaFoldDB

No variants for Q3K110

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q3K110

No associated diseases with Q3K110

6 regional properties for Q3K110

Type Name Position InterPro Accession
domain DNA gyrase B subunit, C-terminal 579 - 640 IPR002288
domain Histidine kinase/HSP90-like ATPase 40 - 184 IPR003594
domain TOPRIM domain 429 - 543 IPR006171
domain DNA topoisomerase, type IIA, subunit B, domain 2 232 - 401 IPR013506
conserved_site DNA topoisomerase, type IIA, conserved site 433 - 441 IPR018522
domain DNA gyrase subunit B, TOPRIM domain 430 - 542 IPR034160

Functions

Description
EC Number 1.7.1.7 With NAD(+) or NADP(+) as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
GMP reductase complex An oxidoreductase complex which is capable of GMP reductase activity. It catalyses the irreversible reaction: GMP + 2 H(+) + NADPH => IMP + NADP(+) + NH(4)(+).

1 GO annotations of molecular function

Name Definition
GMP reductase activity Catalysis of the reaction: IMP + NADP(+) + NH(4)(+) = GMP + 2 H(+) + NADPH.

1 GO annotations of biological process

Name Definition
purine nucleotide metabolic process The chemical reactions and pathways involving a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MFNDIPVFDY EDIQLIPNKC IISSRSQADT SVKLGNYTFK LPVIPANMQT IIDEEVAETL
70 80 90 100 110 120
ACEGYFYIMH RFNEEARRPF IKRMHDKGLI ASISVGVKDY EYDFVTSLKE DAPEFITIDI
130 140 150 160 170 180
AHGHSNSVIE MIQHIKQELP ETFVIAGNVG TPEAVRELEN AGADATKVGI GPGKVCITKV
190 200 210 220 230 240
KTGFGTGGWQ LAALRWCSKA ARKPIIADGG IRTHGDIAKS IRFGASMVMI GSLFAGHLES
250 260 270 280 290 300
PGKLVEVDGQ QFKEYYGSAS EYQKGEHKNV EGKKILLPVK GRLEDTLTEM QQDLQSSISY
310 320
AGGKELDSLR HVDYVIVKNS IWNGDSI